ClinConnect ClinConnect Logo
Search / Trial NCT06165926

Hypertonic Dextrose Injection and Physical Therapy for Frozen Shoulder

Launched by TRI-SERVICE GENERAL HOSPITAL · Dec 3, 2023

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Frozen Shoulder Hypertonic Dextrose Injection Hydrodilation

ClinConnect Summary

This clinical trial is looking at a new way to help people with frozen shoulder, a condition that causes pain and limits movement in the shoulder. The researchers want to see if using a special injection called hypertonic dextrose, along with a procedure to help stretch the shoulder joint and physical therapy, can reduce pain and improve how well patients can move their shoulders in everyday activities.

To be eligible for this trial, participants must have been diagnosed with frozen shoulder by a doctor, and their symptoms should have lasted for more than three months. They also need to show a significant decrease in shoulder movement compared to their other shoulder. However, individuals with certain conditions, like severe injuries or specific diseases, won't be able to participate. If you join this study, you can expect to receive the treatment being tested, along with guidance from physical therapists to help with your recovery. This trial is not yet recruiting, so keep an eye out for updates if you're interested in participating!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Frozen shoulder is diagnosed by physicians based on the patient's medical history, physical examination, X-ray, and ultrasound reports.
  • 2. The symptoms persist for more than 3 months.
  • 3. There is a reduction of at least 30 degrees in at least two of the affected shoulder joint angles compared to the angles of the healthy side: shoulder flexion, abduction, and external rotation.
  • Exclusion Criteria:
  • 1. Ultrasound of the shoulder muscles reveals a complete tear or massive tear of the rotator cuff tendon or calcific tendinitis.
  • 2. Systemic rheumatic disease.
  • 3. Previous shoulder fracture or surgical intervention.
  • 4. Recent shoulder joint injections within the last 3 months.
  • 5. Acute cervical nerve root compression.
  • 6. Current pregnancy or breastfeeding.
  • 7. Poorly controlled diabetes (intravenous glucose injection may cause temporary blood sugar elevation).
  • 8. Patients with cancer.
  • 9. Cognitive impairment, inability to follow simple instructions, or inability to cooperate with the study procedures.

About Tri Service General Hospital

The Tri-Service General Hospital (TSGH) is a leading medical institution in Taiwan, dedicated to advancing healthcare through innovative clinical research and comprehensive patient care. As a prominent military hospital, TSGH integrates cutting-edge medical practices with rigorous scientific inquiry, fostering a collaborative environment for healthcare professionals and researchers. The hospital is committed to enhancing treatment outcomes and improving public health by conducting a diverse range of clinical trials across various medical specialties, ensuring adherence to the highest ethical standards and regulatory guidelines. Through its research initiatives, TSGH aims to contribute significantly to the global medical community and the advancement of evidence-based medicine.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported